← Back
$MREO All transactions

Mereo BioPharma Group plc

A

$ Value

$0

Shares

66,000

Price

$0

Filed

Feb 27

Insider

Name

Shames Daniel

Title

CIK

0002005702

Roles

Director

Transaction Details

Transaction Date

2026-02-26

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

66,000

Footnotes

Vests in substantially equal monthly installments over a one year period from the February 26, 2026 grant date. | Each American Depositary Share ("ADS") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer. | Deferred restricted stock units ("DRSU") are granted to non-executive directors who elected to receive DRSUs in the form of ADSs in lieu of annual cash compensation. DRSUs vest in substantially equal monthly installments over the plan year following the grant date. Payment of DRSUs in ADSs will generally be made 180 days following separation of service.

Filing Info

Accession No.

0001193125-26-082826

Form Type

4

Issuer CIK

0001719714

Shames Daniel's History

Date Ticker Type Value
2026-02-26 MREO A $0
2026-02-26 MREO A

Other Insiders at MREO (90d)

Insider Bought Sold Last
WYZGA MICHAEL S 2026-02-26
PAKIANATHAN DEEPIKA 2026-02-26
Scots-Knight Denise
Chief Executive Officer
2026-02-01
Lewicki John A.
Chief Scientific Officer
2026-02-01
Yoskowitz Marc J 2026-02-26
Jenkins Annalisa 2026-02-26
Sermon Charles
General Counsel
2026-02-01
Jacquet Pierre 2026-02-26
Bender Jeremy 2026-02-26
Shames Daniel 2026-02-26
Fox Christine Ann
Chief Financial Officer
2026-02-01
Ekblom Anders 2026-02-26
Hughes-Wilson Alexandra
See Remarks
2026-02-01